The skin replacement market share is expected to increase at a 6.4 percent CAGR from US$ 838.0 million in 2018 to US$ 1,202.2 million in 2024. FMI, in its upcoming business report, elaborates the historical and current scenario of the global Skin Replacement market in terms of production, consumption, volume, and value. The report scrutinizes the market into various …
Category Archives: Healthcare Trends
Therapeutic Drug Monitoring Market is projected to register a CAGR of 9.7% from 2022 to 2032
[250 Pages Report] The therapeutic drug monitoring market is predicted to register a CAGR of 9.7% during the forecast period 2022 to 2032. The therapeutic drug monitoring market is anticipated to witness opulent growth with a phenomenal CAGR of 9.7% during the forecast period, up from US$ 1.5 Billion in 2020 to reach a valuation of US$ …
Protein Crystallization and Crystallography Market Size to be worth US$ 2.23 Bn by 2028 | FMI
[250 Pages Report] The global protein crystallization and crystallography market is estimated to reach US$ 2.23 billion in 2028. Proteins are the organic macromolecules that are composed of long chain of amino acids. Protein crystallization and crystallography is the process for the formation of small protein crystals. This process is widely used by industrial and scientific purposes. Proteins normally …
Injectable Drugs Market is projected to reach US$ 937.0 Billion by the end of 2032
[341 Pages Report] Cancer, cardiovascular diseases, and metabolic diseases like diabetes, are the main cause of mortality and disability in present times. Even with the understanding of scientific disease indications, it is crucial to elevate diagnosis and control the symptoms and signs of illness. According to the Future Market Insights’ analysis, the injectable drugs market is set to …
Microbial Gene Editing Services Market to be valued at US$ 30.5 Billion from 2022 to 2032 | FMI Study
Microbial gene editing is technology which have the ability to change the DNA of organism. Microbial gene editing is changing the ways for developing new medical treatment. From treating diseases such as sickle cell and HIV to custom pets and designer babies, microbial gene editing has great potential to affect in all the areas of live …
Ovulation Test Kit Market is likely to expand to US$ 450 Million by 2032 | FMI Study
[Report of 307 Pages] The global ovulation test kit market was worth US$ 180 million in 2021 and is expected to grow 8.6% year on year to be worth US$ 195 million in 2022. Rapidly increasing sustaining pregnancy is expected to be a major driver for the Ovulation Test Kit market, which is expected to reach US$ …
Pressure Infusion Cuffs Market set to reach a valuation of US$ 573.2 Million by 2032 | Exclusive Report by FMI
[Report of 428 Pages] Pressure infusion cuff demand is anticipated to grow at a 6.3% CAGR between 2022 and 2032, surpassing a valuation of about US$ 311.7 Mn in 2022. By 2032, sales of pressure infusion cuffs are anticipated to be worth US$ 573.2 million. In terms of application, the blood & drug infusions segment commanded a …
Infectious Disease Molecular Diagnostics Market is likely to reach a valuation of nearly US$ 53 billion by the end of 2032
In 2021, the global Infectious Disease Molecular Diagnostics Market was estimated to be worth approximately US$ 34 billion. With a projected CAGR of 4.2% over the next ten years, the market is expected to be worth nearly US$ 53 billion by the end of 2032. Rather than the traditional methods that required pathogen culture, developers …
Surgical Drainage Devices Market | Acelity, Teleflex Incorporated, Cardinal Health, Medtronic | By 2032
According to a recent market survey conducted by Future Market Insights (FMI), the global Surgical Drainage Devices Market was valued at US$ 1.3 billion in 2021 and is expected to reach US$ 2.9 billion by 2032. The market for Active Drains is expected to grow at a CAGR of 7.8% between 2022 and 2032. Between 2017 and …
Home Healthcare Market Share 2023 to 2033 | By Baxter, ConvaTec, Medtronic, Coloplast, Humana
The Home Healthcare Market Revenue is anticipated to be worth US$ 3.2 billion in 2023 and US$ 4.4 billion by 2033. The market is estimated to increase at a CAGR of 3.1% during the forecast period. The increased need for home healthcare, as well as an increase in chronic patients, complex drugs, and an ageing …